Biochemical freedom from failure
WebNov 11, 2014 · Kaplan–Meier estimates of freedom from biochemical failure (FFBF) were used to describe the patients overall, and comparisons were accomplished using log-rank statistics (16, 17). Simple Cox proportional hazards regression modeling was used to estimate hazard ratios for categorical variables of interest. The overall sample was … WebFeb 1, 2009 · Patients were stratified on the basis of age: {<=}60 (n = 378) and >60 years (n = 1,287). Biochemical failure was defined as a prostate-specific antigen (PSA) nadir plus 2 ng/mL. Univariate and multivariate analyses were used to determine the association of variables with freedom from biochemical failure (FFbF).
Biochemical freedom from failure
Did you know?
WebNov 2, 2007 · The end point for the trial was biochemical freedom from failure, and follow-up ranged from 2 to 16 years (median, 5 years). The researchers found that young men had biochemical outcomes... http://acronymsandslang.com/definition/530053/FFBF-meaning.html#:~:text=FFBF%20means%20Freedom%20from%20Biochemical%20Failure%20This,acronym%2Fslang%20usually%20belongs%20to%20Medical%20%26%20Science%20category.
WebDec 1, 2024 · Biochemical freedom from failure was 80% at 2 years with 3 out of 4 of the biochemical failures exhibiting recurrent local disease. Conclusions. PSMA-directed … WebSep 7, 2024 · The median time to biochemical recurrence was 41.9 (range, 21.4–114.4) months, and almost all patients had a recurrence during the off-phase of ADT. Moreover, mortalities occurred in five patients, including two PC mortalities. The other causes of deaths were due to hematopoietic tumors and biliary tract cancer. Fig. 1
WebMay 9, 2024 · BCR = biochemical recurrence BED = biologically effective dose bFFF = biochemical freedom from failure bPFS = biochemical progression-free survival BT = brachytherapy CSS = cancer-specific survival DE-EBRT = dose-escalated external beam radiation therapy DFS = disease-free survival EORTC = European Organization for … WebJan 1, 2008 · Background: The American Society for Therapeutic Radiology and Oncology (ASTRO) definition of biochemical failure (BF) incorporates backdating, resulting in an artificial flattening of Kaplan-Meier curves and overly favorable estimates when follow-up is short. The nadir + 2 ng/mL (Nadir + 2; Phoenix) definition reduces these artifacts. The …
WebSep 25, 2024 · In the current study, PSA nadir >0.6 was highly predictive of biochemical failure. This is consistent with the previous literature, …
WebJun 30, 2015 · The primary endpoint was 24 month biochemical freedom from failure (the “Phoenix” definition). Subjects underwent biopsy for cause (rising PSA) or at the end of study (24 months). Adverse events were assessed at each postoperative visit and reported as mild, moderate or severe and related to the device or procedure at 24 months. ... circular saw teeth count guideWebFeb 1, 2011 · In 648 men at high risk the biochemical freedom from failure rate was 67% and significant predictors were hormonal therapy, Gleason score and biologically effective dose (p = 0.036, <0.001 and... circular saw teeth directionWebWith longer follow-up, Tendulkar and colleagues 83 demonstrated an improvement in metastasis-free survival in addition to biochemical recurrence. The freedom from biochemical failure decreased from 71% for those with a presalvage PSA of 0.01 to 0.2 … Peyman Hadji, in Marcus and Feldman's Osteoporosis (Fifth Edition), 2024. … With a median follow-up of 7.8 years, 10-year freedom from biochemical failure … diamond group collectiondiamond group gatesheadWebBiochemical freedom from failure (BFFF) was computed by the Phoenix definition, freedom from metastasis (FFM) in men with BF by absence of a positive bone or CT scan and cause-specific survival (CSS) by freedom from death in men with clinical recurrence. Association of risk features to +SVB were compared by chi-square and linear regression … diamond group corporationWebNov 1, 2000 · Freedom from biochemical failure was defined as a serum PSA < or = 0.5 ng/mL at last follow-up. The biochemical control rate at 3 years for all 499 patients was 86%, with 348 patients followed ... circular saw that will cut 3 inchesWebJul 29, 2010 · Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical … diamond group holdings limited